Bin Yu

6.2k total citations · 1 hit paper
183 papers, 4.9k citations indexed

About

Bin Yu is a scholar working on Molecular Biology, Biomedical Engineering and Genetics. According to data from OpenAlex, Bin Yu has authored 183 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 33 papers in Biomedical Engineering and 31 papers in Genetics. Recurrent topics in Bin Yu's work include Virus-based gene therapy research (31 papers), Dental materials and restorations (25 papers) and Nanoplatforms for cancer theranostics (21 papers). Bin Yu is often cited by papers focused on Virus-based gene therapy research (31 papers), Dental materials and restorations (25 papers) and Nanoplatforms for cancer theranostics (21 papers). Bin Yu collaborates with scholars based in China, South Korea and Hong Kong. Bin Yu's co-authors include Yong‐Keun Lee, Tianyan You, Libo Li, Xianghui Yu, Hongzhang Chen, Jin‐Soo Ahn, Lehui Lu, Ho‐Nam Lim, Haihong Zhang and Chunhuan Jiang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Bin Yu

179 papers receiving 4.8k citations

Hit Papers

Defect Engineering Enables Synergistic Action of Enzyme-M... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Yu China 39 1.6k 1.2k 995 896 458 183 4.9k
Li Huang China 38 2.1k 1.3× 286 0.2× 364 0.4× 324 0.4× 235 0.5× 269 4.9k
Yumei Zhang China 40 1.8k 1.1× 3.5k 2.9× 1.7k 1.7× 542 0.6× 93 0.2× 138 6.3k
Martha S. Ribeiro Brazil 39 572 0.4× 1.8k 1.5× 564 0.6× 388 0.4× 31 0.1× 175 5.5k
Qun Ren Switzerland 43 2.3k 1.5× 1.3k 1.1× 738 0.7× 97 0.1× 169 0.4× 156 5.9k
Saravanan Sekaran India 38 847 0.5× 2.5k 2.1× 654 0.7× 155 0.2× 97 0.2× 101 5.0k
Leming Sun United States 27 1.1k 0.7× 1.0k 0.9× 584 0.6× 300 0.3× 25 0.1× 52 3.2k
Mahmoud Rouabhia Canada 46 1.7k 1.1× 1.6k 1.3× 194 0.2× 63 0.1× 109 0.2× 210 7.2k
Philip W. Wertz United States 57 3.7k 2.3× 343 0.3× 146 0.1× 449 0.5× 180 0.4× 174 11.1k
Luciano Paulino Silva Brazil 35 1.3k 0.8× 691 0.6× 590 0.6× 120 0.1× 361 0.8× 208 4.0k
Dafu Chen China 40 1.3k 0.8× 3.0k 2.5× 844 0.8× 76 0.1× 246 0.5× 202 6.6k

Countries citing papers authored by Bin Yu

Since Specialization
Citations

This map shows the geographic impact of Bin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Yu more than expected).

Fields of papers citing papers by Bin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Yu. The network helps show where Bin Yu may publish in the future.

Co-authorship network of co-authors of Bin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Yu. A scholar is included among the top collaborators of Bin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Yu. Bin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Guan‐Jun, Yanjun Liu, Jinjin Shi, et al.. (2024). PRMT7 in cancer: Structure, effects, and therapeutic potentials. European Journal of Medicinal Chemistry. 283. 117103–117103. 2 indexed citations
3.
Wang, Shiqi, Kaifeng Liu, Xin Yu, et al.. (2024). Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction. Viruses. 16(4). 490–490.
4.
Wang, Yanan, Joshua S. Fleishman, Bing Hao, et al.. (2024). Research progress on gene mutations and drug resistance in leukemia. Drug Resistance Updates. 79. 101195–101195. 4 indexed citations
5.
Li, Weiting, Guoqing Li, Yuyang Liu, et al.. (2024). Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection. AIDS. 39(3). 229–240. 1 indexed citations
6.
Huang, Jiaxing, Mo Zhang, Rui Zhu, et al.. (2023). Periodic Mesoporous Organosilica as a Nanoadjuvant for Subunit Vaccines Elicits Potent Antigen-Specific Germinal Center Responses by Activating Naive B Cells. ACS Nano. 17(16). 15424–15440. 5 indexed citations
7.
Yu, Xin, Chu Wang, Tiejun Gu, et al.. (2022). Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction. Journal of Virology. 96(17). e0055522–e0055522. 4 indexed citations
8.
Wang, Siqi, et al.. (2022). 20(s)-ginsenoside Rh2 promotes TRAIL-induced apoptosis by upregulating DR5 in human hepatocellular carcinoma cells. Medical Oncology. 39(7). 70–70. 4 indexed citations
9.
Li, Rong, Xian Jia, Bin Yu, et al.. (2021). IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nature Communications. 12(1). 2537–2537. 74 indexed citations
10.
Bauer, Michael, Bin Yu, Birgit Dreier, et al.. (2021). The RGD-binding integrins αvβ6 and αvβ8 are receptors for mouse adenovirus-1 and -3 infection. PLoS Pathogens. 17(12). e1010083–e1010083. 15 indexed citations
11.
Wang, Wei, Chu Wang, Tiejun Gu, et al.. (2017). Development of broad neutralization activity in simian/human immunodeficiency virus-infected rhesus macaques after long-term infection. AIDS. 32(5). 555–563. 9 indexed citations
12.
Qiu, Xia, Fei Geng, Fang-Fang Zhang, et al.. (2016). Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma. Immunopharmacology and Immunotoxicology. 39(1). 37–44. 28 indexed citations
13.
Zhang, Haihong, Chenlu Liu, Fang-Fang Zhang, et al.. (2016). MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model. Vaccine. 34(24). 2648–2655. 24 indexed citations
14.
Li, Changxian, Bin Yu, Lei Shi, et al.. (2016). ‘Obligate’ anaerobic Salmonella strain YB1 suppresses liver tumor growth and metastasis in nude mice. Oncology Letters. 13(1). 177–183. 26 indexed citations
15.
Yu, Bin, Lei Shi, Ke Zhang, et al.. (2015). Obligate anaerobic Salmonella typhimurium strain YB1 treatment on xenograft tumor in immunocompetent mouse model. Oncology Letters. 10(2). 1069–1074. 15 indexed citations
16.
Yu, Bin, Yan Zhou, Hao Wu, et al.. (2012). Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China. Journal of Medical Virology. 84(9). 1408–1414. 50 indexed citations
17.
Lee, Yong‐Keun, Bin Yu, Guangfeng Zhao, & Jin Ik Lim. (2010). Effects of aging and HEMA content on the translucency, fluorescence, and opalescence properties of experimental HEMA-added glass ionomers. Dental Materials Journal. 29(1). 9–14. 7 indexed citations
18.
Yu, Bin, et al.. (2008). The association of Sclerotinia sclerotiorum resistance with glucosinolates in Brassica napus double-low DH population.. Journal of Plant Pathology. 90(1). 43–48. 8 indexed citations
19.
Kim, Bong‐Joon, Bin Yu, & Yong‐Keun Lee. (2008). Shade distribution of indirect resin composites compared with a shade guide. Journal of Dentistry. 36(12). 1054–1060. 9 indexed citations
20.
Yu, Bin & Yong‐Keun Lee. (2008). Influence of color parameters of resin composites on their translucency. Dental Materials. 24(9). 1236–1242. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026